158 related articles for article (PubMed ID: 38391226)
1. Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants.
Dash P; Hakim A; Akter A; Banna HA; Kaisar MH; Aktar A; Jahan SR; Ferdous J; Basher SR; Kamruzzaman M; Chowdhury F; Akter A; Tauheed I; Weil AA; Charles RC; Calderwood SB; Ryan ET; LaRocque RC; Harris JB; Bhuiyan TR; Qadri F
mSphere; 2024 Mar; 9(3):e0056523. PubMed ID: 38391226
[TBL] [Abstract][Full Text] [Related]
2. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh.
Akter A; Dash P; Aktar A; Jahan SR; Afrin S; Basher SR; Hakim A; Lisa AK; Chowdhury F; Khan AI; Xu P; Charles RC; Kelly M; Kováč P; Harris JB; Bhuiyan TR; Calderwood SB; Ryan ET; Qadri F
PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007634. PubMed ID: 31369553
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1.
Kelly M; Jeon S; Yun J; Lee B; Park M; Whang Y; Lee C; Charles RC; Bhuiyan TR; Qadri F; Kamruzzaman M; Cho S; Vann WF; Xu P; Kováč P; Ganapathy R; Lynch J; Ryan ET
Am J Trop Med Hyg; 2023 Nov; 109(5):1122-1128. PubMed ID: 37783453
[TBL] [Abstract][Full Text] [Related]
4. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.
Alam MM; Riyadh MA; Fatema K; Rahman MA; Akhtar N; Ahmed T; Chowdhury MI; Chowdhury F; Calderwood SB; Harris JB; Ryan ET; Qadri F
Clin Vaccine Immunol; 2011 May; 18(5):844-50. PubMed ID: 21346055
[TBL] [Abstract][Full Text] [Related]
5. Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139.
Kamruzzaman M; Kelly M; Charles RC; Harris JB; Calderwood SB; Akter A; Biswas R; Kaisar MH; Bhuiyan TR; Ivers LC; Ternier R; Jerome JG; Pfister HB; Lu X; Soliman SE; Ruttens B; Saksena R; Mečárová J; Čížová A; Qadri F; Bystrický S; Kováč P; Xu P; Ryan ET
mSphere; 2021 Aug; 6(4):e0011421. PubMed ID: 34232076
[TBL] [Abstract][Full Text] [Related]
6. Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh.
Aktar A; Rahman MA; Afrin S; Akter A; Uddin T; Yasmin T; Sami MIN; Dash P; Jahan SR; Chowdhury F; Khan AI; LaRocque RC; Charles RC; Bhuiyan TR; Mandlik A; Kelly M; Kováč P; Xu P; Calderwood SB; Harris JB; Qadri F; Ryan ET
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006399. PubMed ID: 29684006
[TBL] [Abstract][Full Text] [Related]
7. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.
Islam K; Hossain M; Kelly M; Mayo Smith LM; Charles RC; Bhuiyan TR; Kováč P; Xu P; LaRocque RC; Calderwood SB; Simon JK; Chen WH; Haney D; Lock M; Lyon CE; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Harris JB; Qadri F; Ryan ET
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006376. PubMed ID: 29624592
[TBL] [Abstract][Full Text] [Related]
8. O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh.
Aktar A; Rahman MA; Afrin S; Faruk MO; Uddin T; Akter A; Sami MIN; Yasmin T; Chowdhury F; Khan AI; Leung DT; LaRocque RC; Charles RC; Bhuiyan TR; Mandlik A; Kelly M; Kováč P; Xu P; Calderwood SB; Harris JB; Qadri F; Ryan ET
Clin Vaccine Immunol; 2016 May; 23(5):427-435. PubMed ID: 27009211
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera.
Uddin T; Aktar A; Xu P; Johnson RA; Rahman MA; Leung DT; Afrin S; Akter A; Alam MM; Rahman A; Chowdhury F; Khan AI; Bhuiyan TR; Bufano MK; Rashu R; Yu Y; Wu-Freeman Y; Harris JB; LaRocque RC; Charles RC; Kováč P; Calderwood SB; Ryan ET; Qadri F
Am J Trop Med Hyg; 2014 May; 90(5):873-81. PubMed ID: 24686738
[TBL] [Abstract][Full Text] [Related]
10. Comparison of O-specific polysaccharide responses in patients following infection with
Kaisar MH; Kelly M; Kamruzzaman M; Bhuiyan TR; Chowdhury F; Khan AI; LaRocque RC; Calderwood SB; Harris JB; Charles RC; Čížová A; Mečárová J; Korcová J; Bystrický S; Kováč P; Xu P; Qadri F; Ryan ET
mSphere; 2023 Oct; 8(5):e0025523. PubMed ID: 37646517
[TBL] [Abstract][Full Text] [Related]
11. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice.
Sayeed MA; Bufano MK; Xu P; Eckhoff G; Charles RC; Alam MM; Sultana T; Rashu MR; Berger A; Gonzalez-Escobedo G; Mandlik A; Bhuiyan TR; Leung DT; LaRocque RC; Harris JB; Calderwood SB; Qadri F; Vann WF; Kováč P; Ryan ET
PLoS Negl Trop Dis; 2015; 9(7):e0003881. PubMed ID: 26154421
[TBL] [Abstract][Full Text] [Related]
12. Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba.
Hossain M; Islam K; Kelly M; Mayo Smith LM; Charles RC; Weil AA; Bhuiyan TR; Kováč P; Xu P; Calderwood SB; Simon JK; Chen WH; Lock M; Lyon CE; Kirkpatrick BD; Cohen M; Levine MM; Gurwith M; Leung DT; Azman AS; Harris JB; Qadri F; Ryan ET
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007874. PubMed ID: 31743334
[TBL] [Abstract][Full Text] [Related]
13. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh.
Leung DT; Uddin T; Xu P; Aktar A; Johnson RA; Rahman MA; Alam MM; Bufano MK; Eckhoff G; Wu-Freeman Y; Yu Y; Sultana T; Khanam F; Saha A; Chowdhury F; Khan AI; Charles RC; Larocque RC; Harris JB; Calderwood SB; Kovác P; Qadri F; Ryan ET
Clin Vaccine Immunol; 2013 Jun; 20(6):780-8. PubMed ID: 23515016
[TBL] [Abstract][Full Text] [Related]
14. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.
Leung DT; Rahman MA; Mohasin M; Patel SM; Aktar A; Khanam F; Uddin T; Riyadh MA; Saha A; Alam MM; Chowdhury F; Khan AI; Charles R; LaRocque R; Harris JB; Calderwood SB; Qadri F; Ryan ET
Clin Vaccine Immunol; 2012 May; 19(5):690-8. PubMed ID: 22441386
[TBL] [Abstract][Full Text] [Related]
15. Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.
Kaisar MH; Bhuiyan MS; Akter A; Saleem D; Iyer AS; Dash P; Hakim A; Chowdhury F; Khan AI; Calderwood SB; Harris JB; Ryan ET; Qadri F; Charles RC; Bhuiyan TR
mSphere; 2021 Apr; 6(2):. PubMed ID: 33910997
[TBL] [Abstract][Full Text] [Related]
16. Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide.
Alam MM; Bufano MK; Xu P; Kalsy A; Yu Y; Freeman YW; Sultana T; Rashu MR; Desai I; Eckhoff G; Leung DT; Charles RC; LaRocque RC; Harris JB; Clements JD; Calderwood SB; Qadri F; Vann WF; Kováč P; Ryan ET
PLoS Negl Trop Dis; 2014 Feb; 8(2):e2683. PubMed ID: 24516685
[TBL] [Abstract][Full Text] [Related]
17. Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera.
Johnson RA; Uddin T; Aktar A; Mohasin M; Alam MM; Chowdhury F; Harris JB; LaRocque RC; Bufano MK; Yu Y; Wu-Freeman Y; Leung DT; Sarracino D; Krastins B; Charles RC; Xu P; Kovác P; Calderwood SB; Qadri F; Ryan ET
Clin Vaccine Immunol; 2012 Nov; 19(11):1712-21. PubMed ID: 22993410
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of antibody-secreting cell and fecal IgA responses after oral cholera vaccination in different age groups in a cholera endemic country.
Akhtar M; Qadri F; Bhuiyan TR; Akter S; Rafique TA; Khan A; Islam LN; Saha A; Svennerholm AM; Lundgren A
Vaccine; 2017 Jan; 35(2):321-328. PubMed ID: 27916412
[TBL] [Abstract][Full Text] [Related]
20. Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine.
Akter A; Kelly M; Charles RC; Harris JB; Calderwood SB; Bhuiyan TR; Biswas R; Xu P; Kováč P; Qadri F; Ryan ET
Am J Trop Med Hyg; 2021 Apr; 104(6):2024-2030. PubMed ID: 33872211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
